EUROFINS NTD LLC
NPI: 1992779664
· MELVILLE, NY 11747
· Clinical Medical Laboratory
· NPI assigned 02/17/2006
$5.05M
Total Medicaid Paid
Provider Details
Related Entities
Other providers sharing the same authorized official: URBANEK, MATTHEW
Monthly Spending Trend
Yearly Breakdown
| Year | Claims | Total Paid |
|---|
| 2018 |
143,728 |
$1.44M |
| 2019 |
124,526 |
$1.35M |
| 2020 |
111,137 |
$1.07M |
| 2021 |
66,411 |
$753K |
| 2022 |
22,430 |
$428K |
Billing Codes
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 82105 |
|
149,319 |
138,731 |
$1.52M |
| 84704 |
|
115,265 |
107,277 |
$1.14M |
| 84163 |
|
108,122 |
101,089 |
$1.05M |
| 86336 |
|
35,179 |
32,764 |
$329K |
| 81509 |
|
3,309 |
2,919 |
$320K |
| 83520 |
|
30,102 |
27,923 |
$213K |
| 81508 |
|
15,398 |
13,888 |
$206K |
| 82677 |
|
8,739 |
8,157 |
$131K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,525 |
985 |
$107K |
| 81511 |
|
463 |
436 |
$19K |
| 81400 |
|
656 |
636 |
$7K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
18 |
14 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
72 |
71 |
$2K |
| 99080 |
|
65 |
54 |
$0.00 |